Unraveling the mystery of insulin resistance: from principle mechanistic insights and consequences to therapeutic interventions
10.3390/ijms26062770 · doi-reference
Insulin resistance, non-alcoholic fatty liver disease and type 2 diabetes mellitus: clinical and experimental perspective
10.4093/dmj.2023.0350 · doi-reference
Non-linear association between metabolic score for insulin resistance and nonalcoholic fatty liver disease: analysis of US National Health and Nutrition Examination Survey data, 2017-2020
10.1186/s12902-025-01988-z · doi-reference
Use of metabolic scores and lipid ratios to predict metabolic dysfunction-associated steatotic liver disease onset in patients with inflammatory bowel diseases
10.3390/jcm14092973 · doi-reference
Dose-response associations of metabolic score for insulin resistance index with nonalcoholic fatty liver disease among a nonobese Chinese population: retrospective evidence from a population-based cohort study
10.1155/2022/4930355 · doi-reference
Mets-IR as a predictor of cardiovascular events in the middle-aged and elderly population and mediator role of blood lipids
10.3389/fendo.2023.1224967 · doi-reference
Nonlinear relationship between body fat percentage and NAFLD mediated by METS-IR: threshold effects and subgroup differences
10.1038/s41598-025-10765-w · doi-reference
Identification of pediatric MASLD using insulin resistance indices
10.1016/j.jhepr.2025.101419 · doi-reference
METS-IR/HOMA-IR and MAFLD in US adults: dose-response correlation and the effect mediated by physical activity
10.1186/s12902-024-01646-w · doi-reference
The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults
10.3350/cmh.2022.0099 · doi-reference
METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes
10.1530/eje-17-0883 · doi-reference
Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001-2018
10.1186/s12933-024-02334-8 · doi-reference
TG/HDL-C ratio is positively associated with risk and severity of CHD among NAFLD patients: a case control study
10.3389/fendo.2024.1383489 · doi-reference
Triglyceride to HDL cholesterol ratio for the identification of MASLD in obesity: a liver biopsy-based case-control study
10.3390/nu16091310 · doi-reference
Association between triglyceride to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease and liver fibrosis in American adults: an observational study from the National Health and Nutrition Examination Survey 2017-2020
10.3389/fendo.2024.1362396 · doi-reference
Application of TG/HDL-C combined with liver function indexes to predict metabolic-associated fatty liver disease
10.12182/20220960102 · doi-reference
Impact of inflammatory and insulin resistance biomarkers on long-term risks in coronary heart disease patients with cardiovascular-kidney-metabolic syndrome
10.1161/circ.150.suppl_1.4140042 · doi-reference
Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank
10.1038/s41588-023-01625-2 · doi-reference
Association between triglyceride-glucose related indices and severe infection requiring hospital admission or resulting in mortality among individuals with metabolic dysfunction-associated steatotic liver disease
10.1016/j.clnu.2025.04.006 · doi-reference
Association of triglyceride glucose-body mass index with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
10.1371/journal.pone.0324483 · doi-reference
Diagnosis of metabolic dysfunction-associated steatotic liver disease by triglyceride glucose-body mass index: a systematic review and meta-analysis
10.1016/j.aohep.2025.102122 · doi-reference
Association between triglyceride-glucose related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank
10.1186/s12933-024-02572-w · doi-reference
Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome
10.1186/s12876-023-03095-6 · doi-reference
Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: triglyceride glucose index-related parameters
10.3389/fendo.2022.951689 · doi-reference
